Walleye Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Walleye Capital's PFE Position: Q1 2026 in Review
Walleye Capital increased its Pfizer (PFE) stake by 126% in Q1 2026, buying an estimated $15.9M and bringing the position to 1,070,486 shares worth $30.1M. The position accounts for 0.13% of the portfolio, ranked #95.
Walleye Capital first reported a position in PFE in Q3 2019 and has held it in 13 quarters since. The position peaked at $31.9M in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Walleye Capital held 1,070,486 shares of Pfizer worth $30.1M as of Q1 2026.
- Walleye Capital bought 596,980 Pfizer shares in Q1 2026, an estimated $15.9M.
- Pfizer made up 0.13% of Walleye Capital's portfolio in Q1 2026, its #95 holding.
- Walleye Capital first reported a position in Pfizer in Q3 2019 and has held it in 13 quarters since.
- Walleye Capital's Pfizer position peaked at $31.9M in Q4 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.